Cargando…

Correction: The Cytokine Release Inhibitory Drug CRID3 Targets ASC Oligomerisation in the NLRP3 and AIM2 Inflammasomes

Mostrar otras versiones (1)

Detalles Bibliográficos
Autores principales:	Coll, Rebecca C., O'Neill, Luke A. J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2013
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3762986/ http://dx.doi.org/10.1371/annotation/78d328b9-2c8c-4978-84b1-7e6a0b12ada1

Ejemplares similares

The Cytokine Release Inhibitory Drug CRID3 Targets ASC Oligomerisation in the NLRP3 and AIM2 Inflammasomes
por: Coll, Rebecca C., et al.
Publicado: (2011)

Correction: The Cytokine Release Inhibitory Drug CRID3 Targets ASC Oligomerisation in the NLRP3 and AIM2 Inflammasomes
por: Coll, Rebecca C., et al.
Publicado: (2013)

Tyrosine Dephosphorylation of ASC Modulates the Activation of the NLRP3 and AIM2 Inflammasomes
por: Mambwe, Bezaleel, et al.
Publicado: (2019)

Artemisia Extract Suppresses NLRP3 and AIM2 Inflammasome Activation by Inhibition of ASC Phosphorylation
por: Kwak, Su-Bin, et al.
Publicado: (2018)

Prion Pathogenesis in the Absence of NLRP3/ASC Inflammasomes
por: Nuvolone, Mario, et al.
Publicado: (2015)

MCC950/CRID3 potently targets the NACHT domain of wild-type NLRP3 but not disease-associated mutants for inflammasome inhibition
por: Vande Walle, Lieselotte, et al.
Publicado: (2019)

ASC deglutathionylation is a checkpoint for NLRP3 inflammasome activation
por: Li, Shuhang, et al.
Publicado: (2021)

Suppression of Glucagon-Like Peptide-1 Release by Inhibition of Intestinal NLRP3 Inflammasome Activation in Asc(–/–) and Nlrp3(–/–) Mice
por: Chen, Yu, et al.
Publicado: (2019)

Correction: MCC950/CRID3 potently targets the NACHT domain of wild-type NLRP3 but not disease-associated mutants for inflammasome inhibition
por: Walle, Lieselotte Vande, et al.
Publicado: (2019)

The ASC Speck and NLRP3 Inflammasome Function Are Spatially and Temporally Distinct
por: Nagar, Abhinit, et al.
Publicado: (2021)

Tanshinone I specifically suppresses NLRP3 inflammasome activation by disrupting the association of NLRP3 and ASC
por: Zhao, Jia, et al.
Publicado: (2023)

NLRP3, the inflammasome and COVID-19 infection
por: Yin, Maureen, et al.
Publicado: (2023)

The Supportive Role of NSC328382, a P2X7R Antagonist, in Enhancing the Inhibitory Effect of CRID3 on NLRP3 Inflammasome Activation in Rats with Dextran Sodium Sulfate-Induced Colitis
por: Saber, Sameh, et al.
Publicado: (2021)

Pyk2 activates the NLRP3 inflammasome by directly phosphorylating ASC and contributes to inflammasome-dependent peritonitis
por: Chung, I-Che, et al.
Publicado: (2016)

SARS-CoV-2 infects blood monocytes to activate NLRP3 and AIM2 inflammasomes, pyroptosis and cytokine release
por: Junqueira, Caroline, et al.
Publicado: (2021)

The Role of NLRP1, NLRP3, and AIM2 Inflammasomes in Psoriasis: Review
por: Ciążyńska, Magdalena, et al.
Publicado: (2021)

Adenovirus VA RNAI Blocks ASC Oligomerization and Inhibits NLRP3 Inflammasome Activation
por: Darweesh, Mahmoud, et al.
Publicado: (2019)

What are NLRP3-ASC specks? an experimental progress of 22 years of inflammasome research
por: Nagar, Abhinit, et al.
Publicado: (2023)

Structure, Activation and Regulation of NLRP3 and AIM2 Inflammasomes
por: Sharma, Meenakshi, et al.
Publicado: (2021)

Fast drift CRID with GEM
por: Vavra, J, et al.
Publicado: (1999)

Ethanol extract of Chrysanthemum zawadskii inhibits the NLRP3 inflammasome by suppressing ASC oligomerization in macrophages
por: Jang, Ah-Ra, et al.
Publicado: (2023)

ASC specks exacerbate α‑synuclein pathology via amplifying NLRP3 inflammasome activities
por: Zheng, Ran, et al.
Publicado: (2023)

A Yersinia Effector with Enhanced Inhibitory Activity on the NF-κB Pathway Activates the NLRP3/ASC/Caspase-1 Inflammasome in Macrophages
por: Zheng, Ying, et al.
Publicado: (2011)

Propofol directly induces caspase-1-dependent macrophage pyroptosis through the NLRP3-ASC inflammasome
por: Sun, Lingbin, et al.
Publicado: (2019)

The Inflammasome Activity of NLRP3 Is Independent of NEK7 in HEK293 Cells Co-Expressing ASC
por: Machtens, Dominik Alexander, et al.
Publicado: (2022)

TIGAR deficiency induces caspase-1-dependent trophoblasts pyroptosis through NLRP3-ASC inflammasome
por: Guo, Junjun, et al.
Publicado: (2023)

Qiqilian ameliorates vascular endothelial dysfunction by inhibiting NLRP3-ASC inflammasome activation in vivo and in vitro
por: Luo, Yuan, et al.
Publicado: (2023)

Diphosphorus Release and Heterocumulene Oligomerisation by Nickel Complexes
por: Hierlmeier, Gabriele, et al.
Publicado: (2022)

Dipeptidyl peptidase-4 inhibition by Saxagliptin prevents inflammation and renal injury by targeting the Nlrp3/ASC inflammasome
por: Birnbaum, Yochai, et al.
Publicado: (2016)

Chalcone Derivatives From Abelmoschus manihot Seeds Restrain NLRP3 Inflammasome Assembly by Inhibiting ASC Oligomerization
por: Su, Jinsong, et al.
Publicado: (2022)

Transcriptional Suppression of the NLRP3 Inflammasome and Cytokine Release in Primary Macrophages by Low-Dose Anthracyclines
por: Köse-Vogel, Nilay, et al.
Publicado: (2019)

Inhibitory effect of PPARγ on NLRP3 inflammasome activation
por: Yang, Ching-Chun, et al.
Publicado: (2021)

PKM2-dependent glycolysis promotes NLRP3 and AIM2 inflammasome activation
por: Xie, Min, et al.
Publicado: (2016)

The mitochondrial protease HtrA2 restricts the NLRP3 and AIM2 inflammasomes
por: Rodrigue-Gervais, Ian Gaël, et al.
Publicado: (2018)

Shikonin Suppresses NLRP3 and AIM2 Inflammasomes by Direct Inhibition of Caspase-1
por: Zorman, Jernej, et al.
Publicado: (2016)

Cytokine Secretion and Pyroptosis of Thyroid Follicular Cells Mediated by Enhanced NLRP3, NLRP1, NLRC4, and AIM2 Inflammasomes Are Associated With Autoimmune Thyroiditis
por: Guo, Qingling, et al.
Publicado: (2018)

Anti-GBM Glomerulonephritis Involves IL-1 but Is Independent of NLRP3/ASC Inflammasome-Mediated Activation of Caspase-1
por: Lichtnekert, Julia, et al.
Publicado: (2011)

Targeting ASC in NLRP3 inflammasome by caffeic acid phenethyl ester: a novel strategy to treat acute gout
por: Lee, Hye Eun, et al.
Publicado: (2016)

AIM2 recognizes cytosolic dsDNA and forms a caspase-1 activating inflammasome with ASC
por: Hornung, Veit, et al.
Publicado: (2009)

Macrophage migration inhibitory factor is required for NLRP3 inflammasome activation
por: Lang, Tali, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_fgu56ajhl37m1mjvfja72ntg68